Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population

被引:77
作者
Inoue, T
Segawa, T
Shiraishi, T
Yoshida, T
Toda, Y
Yamada, T
Kinukawa, N
Kinoshita, H
Kamoto, T
Ogawa, O
机构
[1] Kyoto Univ, Grad Sch Med, Dept Urol, Sakyo Ku, Kyoto 6068507, Japan
[2] Kansai Med Univ, Dept Urol, Moriguchi, Osaka 570, Japan
[3] Kyusyu Univ Hosp, Div Med Informat, Kyushu, Japan
[4] Kyoto Univ, Anat Ctr, Grad Sch Med, Kyoto, Japan
[5] Mie Univ, Sch Med, Dept Pathol 2, Tsu, Mie 514, Japan
关键词
D O I
10.1016/j.urology.2005.02.028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To evaluate multiple known prognostic markers in localized prostate cancer using tissue microarrays in Japanese patients. Molecular studies have suggested that ethnicity influences prostate tumor biology. Methods. Specimens were studied from 52 patients who underwent radical surgery at our institution between 1997 and 2001 without neoadjuvant hormonal therapy and with three or more available and complete cancer spots. Ki67, p53, and androgen receptor antigen expression were examined. Immunohistochemical scores were compared with outcomes of chemical relapse as monitored using prostate-specific antigen. Results. Pathologic tumor classification (P = 0.047), World Health Organization score (P = 0.026), World Health Organization histologic grade (P = 0.026), and surgical margin status (P = 0.018) were significant conventional clinicopathologic variables for predicting biochemical failure. The tissue microarray Gleason sum (P = 0.038), tissue microarray primary Gleason grade (P = 0.013), Ki67 labeling index (P <0.0001), p53 (P = 0.0097), and androgen receptor (P = 0.0113) antigen expression also were significant. Moreover, surgical margin status and Ki67 labeling index were independently associated with treatment failure. Conclusions. Especially together, the Ki67 labeling index and p53 and androgen receptor expression in localized prostate cancer often predicted postoperative progression in Japanese patients.
引用
收藏
页码:332 / 337
页数:6
相关论文
共 30 条
[1]   Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer [J].
Bauer, JJ ;
Sesterhenn, IA ;
Mostofi, FK ;
McLeod, DG ;
Srivastava, S ;
Moul, JW .
JOURNAL OF UROLOGY, 1996, 156 (04) :1511-1516
[2]  
BROOKS DJ, 1996, J UROLOGY, V56, P3814
[3]   Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer [J].
Bubendorf, L ;
Tapia, C ;
Gasser, TC ;
Casella, R ;
Grunder, B ;
Moch, H ;
Mihatsch, MJ ;
Sauter, G .
HUMAN PATHOLOGY, 1998, 29 (09) :949-954
[4]  
Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO
[5]  
2-4
[6]   Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies [J].
Bubendorf, L ;
Nocito, A ;
Moch, H ;
Sauter, G .
JOURNAL OF PATHOLOGY, 2001, 195 (01) :72-79
[7]   Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells [J].
Burchardt, M ;
Burchardt, T ;
Shabsigh, A ;
Ghafar, M ;
Chen, MW ;
Anastasiadis, A ;
de la Taille, A ;
Kiss, A ;
Buttyan, R .
PROSTATE, 2001, 48 (04) :225-230
[8]  
CHEN DC, 2003, NAT MED, V10, P33
[9]   Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer [J].
Han, M ;
Partin, AW ;
Zahurak, M ;
Piantadosi, S ;
Epstein, JI ;
Walsh, PC .
JOURNAL OF UROLOGY, 2003, 169 (02) :517-523
[10]  
Henshall SM, 2001, CANCER RES, V61, P423